Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2305764120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Eunice Y Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Columbia University Irving Medical Center, New York, NY 10032. Hauptthemen laut MEDLINE: Alopecia Areata. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Alopecia Areata Foundation.
Abstract (Originalsprache)
Alopecia areata (AA) is among the most prevalent autoimmune diseases, but the development of innovative therapeutic strategies has lagged due to an incomplete understanding of the immunological underpinnings of disease. Here, we performed single-cell RNA sequencing (scRNAseq) of skin-infiltrating immune cells from the graft-induced C3H/HeJ mouse model of AA, coupled with antibody-based depletion to interrogate the functional role of specific cell types in AA in vivo. Since AA is predominantly T cell-mediated, we focused on dissecting lymphocyte function in AA. Both our scRNAseq and functional studies established CD8+ T cells as the primary disease-driving cell type in AA. Only the depletion of CD8+ T cells, but not CD4+ T cells, NK, B, or γδ T cells, was sufficient to prevent and reverse AA. Selective depletion of regulatory T cells (T reg ) showed that T reg are protective against AA in C3H/HeJ mice, suggesting that failure of T reg -mediated immunosuppression is not a major disease mechanism in AA. Focused analyses of CD8+ T cells revealed five subsets, whose heterogeneity is defined by an “effectorness gradient” of interrelated transcriptional states that culminate in increased effector function and tissue residency. scRNAseq of human AA skin showed that CD8+ T cells in human AA follow a similar trajectory, underscoring that shared mechanisms drive disease in both murine and human AA. Our study represents a comprehensive, systematic interrogation of lymphocyte heterogeneity in AA and uncovers a novel framework for AA-associated CD8+ T cells with implications for the design of future therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY 10032.
- Medical Scientist Training Program, Columbia University, New York, NY 10032.
- Department of Dermatology, Weill Cornell Medicine, New York, NY 10021.
- Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY 10065.
- Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032.
ORCID-Profile: Zhenpeng Dai
Förderung
- NIAMS NIH HHS
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Alopecia Areata Foundation
Zitieren
APA
Lee, E. Y., Dai, Z., Jaiswal, A., Wang, E. H. C., Anandasabapathy, N., & Christiano, A. M. (2023). Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2305764120
Vancouver
Lee EY, Dai Z, Jaiswal A, Wang EHC, Anandasabapathy N, Christiano AM. Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2305764120
BibTeX
@article{Lee2023,
author = {Lee, Eunice Y and Dai, Zhenpeng and Jaiswal, Abhinav and Wang, Eddy Hsi Chun and Anandasabapathy, Niroshana and Christiano, Angela M},
title = {Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2305764120}
}
EUVIMED